Astrazeneca Income Statement (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	0.12B	0.51B	0.26B	0.00B	0.18B	0.16B	0.03B	0.19B	0.10B	0.32B	0.04B	0.00B	0.06B	0.81B	0.07B	14.46B	0.01B	0.01B	0.08B	15.38B
Cost of Revenue (Quarter)	3.76B	4.62B	3.51B	3.00B	2.98B	2.90B	1.91B	1.96B	2.10B	5.96B	2.22B	2.18B	3.08B	2.73B	2.24B	2.47B	2.80B	3.12B	2.68B	2.52B
Gross Profit (Quarter)	6.11B	7.39B	7.88B	7.77B	8.00B	8.31B	8.97B	9.46B	9.40B	27.83B	10.46B	10.76B	10.48B	12.17B	11.35B	11.98B	12.39B	12.38B	12.61B	12.86B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	-3.61B	-2.58B	-2.13B	-2.55B	-2.46B	-2.62B	-2.61B	-2.67B	-2.58B	-3.07B	-2.78B	-3.01B	-3.12B	-4.68B	-3.16B	3.55B	-3.66B	-3.86B	-3.49B	4.05B
Selling, General & Administrative (Quarter)	-4.09B	-5.12B	-4.84B	-4.68B	-4.28B	-4.62B	-4.06B	-4.99B	-4.80B	-5.37B	-4.50B	-4.93B	-5.14B	-5.41B	-4.49B	4.86B	-5.08B	-5.49B	-4.92B	5.65B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.04B	0.15B	0.10B	0.12B	0.11B	0.19B	0.38B	0.78B	0.07B	1.23B	0.07B	0.06B	0.03B	0.10B	0.11B	0.08B	0.09B	0.10B	0.19B	0.15B
Operating Expenses (Quarter)	-7.70B	-7.70B	-7.10B	-7.23B	-6.74B	-7.25B	-6.67B	-7.65B	-7.38B	-8.44B	-7.28B	-7.94B	-8.26B	-10.09B	-7.65B	8.41B	-8.75B	-9.35B	-8.41B	9.70B
Operating Income (Quarter)	-1.67B	-0.29B	0.88B	0.54B	1.25B	2.66B	2.55B	2.46B	1.95B	6.96B	3.12B	2.75B	2.11B	2.04B	3.67B	3.51B	3.58B	2.98B	4.25B	3.16B
EBIT (Quarter)	-1.67B	-0.29B	0.88B	0.54B	1.25B	2.66B	2.55B	2.46B	1.95B	6.96B	3.12B	2.75B	2.11B	2.04B	3.67B	3.51B	3.58B	2.98B	4.25B	3.16B
Non-operating items
Non Operating Interest Expenses (Quarter)	-0.34B	-0.34B	-0.34B	-0.31B	-0.34B	-0.36B	-0.36B	-0.43B	-0.39B	-0.94B	-0.41B	-0.44B	-0.46B	-0.43B	-0.35B	-0.44B	-0.43B	-0.48B	-0.39B
Non Operating Investment Income (Quarter)	0.01B	0.01B	-0.01B	0.04B	-0.00B	-0.04B	0.02B	0.02B	0.01B	-0.00B	0.02B	0.02B	-0.03B	0.03B	-0.01B	-0.01B	0.01B	0.02B	0.00B
Interest & Investment Income (Quarter)	0.01B	0.00B	0.02B	0.02B	0.01B	0.04B	0.08B	0.06B	0.10B	0.11B	0.11B	0.10B	0.18B	0.06B	0.08B	0.07B	0.09B	0.14B	0.07B	0.08B
Other Non Operating Income (Quarter)		-9.74B	-2.13B				-2.61B		-2.58B	-7.86B	-2.78B		-3.12B		-3.16B				-3.49B
Non Operating Income (Quarter)	0.32B	0.34B	0.32B	0.29B			0.29B	0.37B			0.30B	0.34B	0.27B	0.36B	0.27B	0.37B	0.35B	0.35B	0.32B
Net income details
EBT (Quarter)	-2.00B	-0.64B	0.55B	0.25B	0.92B	0.78B	2.26B	2.09B	1.65B	6.00B	2.80B	2.40B	1.83B	1.67B	3.40B	3.56B	3.24B	2.63B	3.91B	2.89B
Tax Provisions (Quarter)	0.35B	0.29B	-0.17B	0.11B	0.72B	0.12B	-0.46B	-0.27B	-0.27B	-1.00B	-0.62B	-0.47B	-0.40B	-0.17B	-0.48B	0.68B	-0.71B	-0.30B	-0.83B	0.29B
Profit After Tax (Quarter)	-0.33B	-0.75B	0.39B	0.36B	1.64B	0.90B	1.80B	1.82B	1.38B	5.00B	2.18B	1.93B	1.43B	1.50B	2.92B	2.45B	2.54B	2.33B	3.08B	2.51B
Equity Income (Quarter)	-0.01B				0.00B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.01B	-0.00B	0.00B	0.01B	0.00B	0.00B
Income from Continuing Operations (Quarter)	-2.35B	-0.93B	0.72B	0.13B	0.20B	0.65B	2.72B	2.36B	1.93B	7.00B	3.42B	2.87B	2.22B	1.83B	3.88B	2.88B	3.95B	2.93B	4.75B	2.60B
Consolidated Net Income (Quarter)	-2.35B	-0.93B	0.72B	0.13B	0.20B	0.65B	2.72B	2.36B	1.93B	7.00B	3.42B	2.87B	2.22B	1.83B	3.88B	2.88B	3.95B	2.93B	4.75B	2.60B
Income towards Parent Company (Quarter)	-1.98B	-0.75B	0.41B	-0.37B	1.64B	1.71B	2.18B	1.82B	1.37B	1.78B	2.18B	1.93B	2.65B	1.50B	4.02B	2.45B	2.58B	2.77B	3.08B	2.51B
Net Income towards Common Stockholders (Quarter)	-1.98B	-0.75B	0.41B	-0.37B	1.64B	1.71B	2.18B	1.82B	1.37B	1.78B	2.18B	1.93B	2.65B	1.50B	4.02B	2.45B	2.58B	2.77B	3.08B	2.51B
Additional items
EPS (Basic) (Quarter)	-3.02	-1.05	0.57	-0.48	2.12	2.21	2.82	2.35	1.77	2.30	2.81	2.49	3.42	1.94	5.18	3.16	3.32	1.79	1.99	1.62
EPS (Diluted) (Quarter)	-3.01	-1.05	0.57	-0.48	2.10	2.19	2.80	2.33	1.76	2.28	2.79	2.47	3.40	1.92	5.14	3.14	3.30	1.77	1.97	1.61
Shares Outstanding (Quarter)	0.66B	0.71B	0.71B	0.77B	0.77B	0.77B	0.77B	0.78B	0.78B	0.77B	0.77B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	1.55B	1.55B	1.55B
Shares Outstanding (Diluted) (Quarter)	0.66B	0.71B	0.71B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	0.78B	1.56B	1.56B	1.56B
Shares Outstanding (Entity) (Quarter)		0.71B		0.77B		0.77B		0.78B		0.77B		0.78B		0.78B		0.78B		1.55B		1.55B
EBITDA (Quarter)	-1.67B	-0.29B	0.88B	0.54B	1.25B	2.66B	2.55B	2.46B	1.95B	6.96B	3.12B	2.75B	2.11B	2.04B	3.67B	3.51B	3.58B	2.98B	4.25B	3.16B
Interest Expenses (Quarter)	-0.20B	-0.52B	-0.19B	0.31B	-0.34B	-0.61B	-0.26B	0.43B	-0.39B	-1.08B	-0.34B	0.44B	-1.93B	-1.31B	-0.42B	0.44B	-1.85B	2.76B	-0.44B	0.43B
Tax Rate (Quarter)	-17.49%	-45.60%	-29.84%	45.75%	78.09%	15.94%	-20.25%	-12.84%	-16.59%	-16.66%	-22.14%	-19.57%	-21.61%	-9.96%	-14.14%	19.09%	-21.86%	-11.41%	-21.28%	10.06%

Research Tools

Datasets

Plans

Developers

Astrazeneca AZN Income Statement (2009-2026)

Research Tools

Datasets

Plans

Developers

Astrazeneca AZN Income Statement (2009-2026)

Create an account

Sign In

Reset Password